Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Zhonglin Hao says small cell lung cancer usually occurs in smokers and often recurs after treatments that are currently ...

DURHAM, N.C. (WTVD) -- Small cell lung cancer is one of the most aggressive and deadly forms of lung cancer commonly associated with smoking. Now, researchers at Duke Health have uncovered a ...

An MSK research team developed a sophisticated method to highlight and track cells with "high plasticity" before and after different treatments in a mouse model of lung cancer. The green cells in this ...

Cancer remains one of the greatest medical challenges for biotechnology firms, even as the oncology medicine market is ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Alveltamig is a trispecific T-cell engager, enhancing immune response by linking T cells to cancer cells with three binding arms. The trial addresses treatment challenges for small cell lung cancer ...

Imdelltra significantly improved progression-free and overall survival compared to chemotherapy in small cell lung cancer patients, with a median overall survival of 13.6 months versus 8.3 months. The ...